We are live on ! Find out more
TSC

Two Seas Capital Portfolio holdings

AUM $7.15B
1-Year Est. Return 169.27%
This Fund
S&P 500
This Quarter Est. Return
+5.9%
1 Year Est. Return
+169.27%
3 Year Est. Return
+279.82%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$617M
AUM Growth
+$1.97M
Cap. Flow
+$21.7M
Cap. Flow %
3.52%
Top 10 Hldgs %
87.84%
Holding
28
New
8
Increased
6
Reduced
10
Closed
2

Top Buys

Rank Stock Value
1
TLN
Talen Energy Corp
TLN
+$63.3M
2
EXEL icon
Exelixis
EXEL
+$11.3M
3
CLMT icon
Calumet Specialty Products
CLMT
+$4.97M
4
CEG icon
Constellation Energy
CEG
+$4.97M
5
INDV icon
Indivior Pharmaceuticals
INDV
+$4.68M

Top Sells

Rank Stock Value
1
ROIV icon
Roivant Sciences
ROIV
+$6.76M
2
CORZ icon
Core Scientific
CORZ
+$5.53M
3
VST icon
Vistra
VST
+$5.21M
4
ARQT icon
Arcutis Biotherapeutics
ARQT
+$4.44M
5
OMEX icon
Odyssey Marine Exploration
OMEX
+$3.94M

Sector Composition

Rank Sector Weight
1 Healthcare 57.12%
2 Utilities 18.87%
3 Technology 12.02%
4 Communication Services 4.41%
5 Financials 1.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INDV icon
1
Indivior Pharmaceuticals
INDV
$4.58B
$127M 20.58%
13,030,027
+400,001
+3% +$4.68M
ROIV icon
2
Roivant Sciences
ROIV
$25B
$112M 18.18%
9,724,893
-593,871
-6% -$6.76M
TLN
3
Talen Energy Corp
TLN
$15.8B
$80.1M 12.97%
+449,115
New +$63.3M
CORZ icon
4
Core Scientific
CORZ
$7B
$67.7M 10.96%
5,705,791
-533,800
-9% -$5.53M
ABUS icon
5
Arbutus Biopharma
ABUS
$913M
$32.3M 5.23%
8,387,388
-184,363
-2% -$707K
VST icon
6
Vistra
VST
$47.4B
$30M 4.85%
252,666
-61,416
-20% -$5.21M
AVDL
7
DELISTED
Avadel Pharmaceuticals
AVDL
$29.6M 4.79%
2,253,780
+138,501
+7% +$2.11M
EXEL icon
8
CALL
Exelixis
EXEL
$14.3B
$23.6M 3.82%
907,900
+796,600
+716% +$19.8M
META icon
9
Meta Platforms (Facebook)
META
$1.5T
$20.6M 3.33%
35,958
+5,000
+16% +$2.57M
IMVT icon
10
Immunovant
IMVT
$8.06B
$19.3M 3.13%
676,614
-15,792
-2% -$466K
EXEL icon
11
Exelixis
EXEL
$14.3B
$11.8M 1.9%
+453,103
New +$11.3M
ESPR
12
DELISTED
Esperion Therapeutics
ESPR
$10.9M 1.76%
6,584,278
+848,618
+15% +$1.71M
SHC icon
13
Sotera Health
SHC
$5.13B
$6.68M 1.08%
400,000
+50,000
+14% +$730K
GOOGL icon
14
Alphabet (Google) Class A
GOOGL
$4.43T
$6.63M 1.07%
40,000
-9,371
-19% -$1.57M
SONO icon
15
Sonos
SONO
$1.88B
$6.5M 1.05%
528,928
-175,000
-25% -$2.22M
CEG icon
16
Constellation Energy
CEG
$94.7B
$6.5M 1.05%
+25,000
New +$4.97M
CLMT icon
17
Calumet Specialty Products
CLMT
$3.51B
$5.52M 0.89%
+310,007
New +$4.97M
ARQT icon
18
Arcutis Biotherapeutics
ARQT
$3.39B
$2.9M 0.47%
312,122
-450,068
-59% -$4.44M
HUT
19
Hut 8
HUT
$10.4B
$2.51M 0.41%
+204,916
New +$2.72M
PCRX icon
20
PUT
Pacira BioSciences
PCRX
$979M
$2.38M 0.39%
+158,400
New +$2.71M
IREN icon
21
Iris Energy
IREN
$13.9B
$2.32M 0.38%
+275,000
New +$2.53M
WULF icon
22
TeraWulf
WULF
$8.95B
$2.02M 0.33%
432,626
-67,374
-13% -$306K
CORZW icon
23
Core Scientific Inc Tranche 1 Warrants
CORZW
$1.48B
$1.89M 0.31%
280,248
– –
BTBT icon
24
Bit Digital
BTBT
$482M
$1.45M 0.23%
+412,414
New +$1.37M
OMEX icon
25
Odyssey Marine Exploration
OMEX
$43.5M
$82.8K 0.01%
100,000
-1,050,666
-91% -$3.94M
1
2

Similar funds

UB
UMB Bank Kansas City, Missouri $7.16B AUM 20.88% 1-Year Est. Return
FPA
First Pacific Advisors El Segundo, California $7.14B AUM 21.51% 1-Year Est. Return
FPP
Findlay Park Partners London, United Kingdom $7.17B AUM 17.27% 1-Year Est. Return
SC
Saturna Capital Bellingham, Washington $7.13B AUM 35.47% 1-Year Est. Return
CFG
Citizens Financial Group Providence, Rhode Island $7.19B AUM 23.93% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
MNA
Manning & Napier Advisors Fairport, New York $7.09B AUM 17.35% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Two Seas Capital's Q3 2024 Portfolio in Review

As of Q3 2024, Two Seas Capital held 28 positions worth $617M, up 0.32% from $615M the previous quarter. Its ten largest holdings account for 88% of the portfolio.

Two Seas Capital deployed $21.7M of net new capital in Q3 2024, opening 8 new positions and adding to 6 existing holdings. Its largest new stake was Talen Energy Corp: 449,115 shares worth $80.1M.

By sector, the portfolio is most concentrated in Healthcare at 57% of assets, down from 67% a quarter earlier, followed by Utilities and Technology.

On the sell side, the largest reduction was Roivant Sciences, an estimated $6.76M trimmed.

  • Two Seas Capital's largest Q3 2024 buy was Talen Energy Corp: 449,115 shares worth $80.1M.
  • Two Seas Capital added most to Indivior Pharmaceuticals in Q3 2024, an estimated $4.68M increase.
  • Two Seas Capital's biggest Q3 2024 reduction was Roivant Sciences, cutting an estimated $6.76M.
  • Two Seas Capital fully exited Core Scientific Inc Tranche 2 Warrants in Q3 2024, selling an estimated $2.02M.
  • Two Seas Capital's ten largest holdings make up 88% of its $617M portfolio in Q3 2024.
  • Two Seas Capital opened 8 new positions and closed 2 in Q3 2024.
  • Two Seas Capital's portfolio value rose 0.32% quarter-over-quarter to $617M.

Based on Two Seas Capital's 13F filing for Q3 2024, filed 14 Nov 2024.